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Background. ICU acquired hypernatremia (IAH, serum sodium concentration (sNa)≥ 143mmol/L) ismainly considered iatrogenic,
induced by sodium overload and water deficit. Main goal of the current paper was to answer the following questions: Can the
development of IAH indeed be explained by sodium intake and water balance? Or can it be explained by renal cation excretion?
Methods.Two retrospective studies were conducted: a balance study in 97 ICU patients with and without IAH and a survey on renal
cation excretion in 115 patients with IAH. Results. Sodium intake within the first 48 hours of ICU admission was 12.5 [9.3–17.5] g in
patients without IAH (𝑛 = 50) and 15.8 [9–21.9] g in patients with IAH (𝑛 = 47), 𝑝 = 0.13. Fluid balance was 2.3 [1–3.7] L and 2.5
[0.8–4.2] L, respectively, 𝑝 = 0.77. Urine cation excretion (urine Na + K) was < sNa in 99 out of 115 patients with IAH. Severity of
illness was the only independent variable predicting development of IAH and low cation excretion, respectively. Conclusion. IAH is
not explained by sodium intake or fluid balance. Patients with IAH are characterized by low urine cation excretion, despite positive
fluid balances. The current paradigm does not seem to explain IAH to the full extent and warrants further studies on sodium
handling in ICU patients.
1. Introduction
ICU acquired hypernatremia (IAH), defined as a serum
sodium concentration (sNa) of more than 145mmol/L, is a
regularly occurring condition in a large variety of intensive
care patients [1]. In previous publications, the incidence of
IAH varies from 3 to 17% [2–5]. We previously reported an
incidence IAH between 6% and 9% [6]. In several studies,
IAH was associated with higher morbidity and mortality
and a prolonged length of stay in the ICU [4, 5, 7–9].
Moreover, recent observations by Darmon et al. confirmed
the association between IAH and mortality with an even
lower cutoff value for sNa ≥ 143mmol/L [7].
Under normal circumstances, sNa is maintained within
relatively narrow limits by osmo- and volume-regulation.
A change in sodium balance is associated with only subtle
changes in sNa [10, 11].Theoretically, hypernatremia is caused
by a disturbance in water homeostasis and sodium content
[12–16]. These mechanisms are derived from the Edelman
equation, which in simplified form is as follows [17]:
[Na+] =
(Total exchangeable Na+ + total excangeable K+)
Total body water
. (1)
In the past decades, IAH is mainly seen as an iatrogenic
complication. On the one hand, excessive sodium intake
during critical illness, attributed to the infusion of sodium-
rich fluids, may play a role [12, 14, 18–20]. On the other hand,
decrease in total body water, caused by renal or extrarenal
water loss, or insufficient water intake may enhance the
rise in sNa. ICU patients either are incapable of swallowing
or have limited access to free water whilst being sedated
during mechanical ventilation [7, 14]. Excessive water loss
can be due to diabetes insipidus, the use of diuretics, osmotic
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diuresis (e.g., in case of high urea excretion), electrolyte disor-
ders, increased or nonreplenished insensible loss, nasogastric
suction, or fluid loss via tubes or drains [12, 19]. Healthy
individuals, subject to intravenous sodium loading, display
increased renal sodium excretion to maintain homeostasis
[21–23]. In critically ill patients, an impaired ability to excrete
cations has been reported, independently of their volume
status [14, 15]. This is in line with our own observations that
consistent reduction of sodium intake, by replacement of all
sodium-rich resuscitation fluids, did not seem to change the
overall incidence of IAH in our own ICU department [6].
As a first step to unravel the aetiology of IAH, we per-
formed two complementary observational studies to answer
the following questions: First, can the development of IAH be
(fully) explained by parameters of sodium intake and water
balance? Or could it be explained by renal cation excretion?
2. Methods
2.1. Patients and Setting. This study consisted of two com-
plementary parts: one balance study and another on renal
cation excretion. The balance study was a single-centre
retrospective cohort analysis in patients admitted to the ICU
from September 2013 until February 2014. The ICU is a 22-
bed combinedmedical and surgical unit in a tertiary teaching
hospital. All patients with a length of stay (LOS) in the ICU
≥ 48 hours were included. Exclusion criteria were sNa ≥
143mmol/L on admission and renal replacement therapy.
Patients were divided into two subgroups: one group of
patients that developed a sNa ≥ 143mmol/L and one group
that did not. An alternative sNa ≥ 145mmol/L cutoff value
was also predefined for secondary analysis.
Simultaneously, a single-centre cohort analysis on renal
cation excretion was performed. As a by-product of an
ongoing trial, spot urine samples were available in patients
with IAH. These samples were obtained as soon as possible
after the occurrence of IAH. Inclusion criteria for this study
were IAH and a LOS ICU ≥ 48 hours. Exclusion criteria
were sNa ≥ 143mmol/L on admission and renal replacement
therapy. Spot urine samples were collected in the period
between September 2013 and April 2015 and retrospectively
analysed. Groups were classified on the assumption that in
nonhypovolemic patients a total renal excretion of sodium
and potassium lower than sNa implies impaired ability of the
kidney to excrete cations [15]. In group 1, total renal cation
excretion (urine (uNa) + urine potassium (uK)) was < sNa.
In group 2, total renal cation was ≥ sNa.
2.2. Data Collection. Data were extracted from the patient
data management system (PDMS). The following patient
characteristics were identified: gender, age, Acute Physiology
and Chronic Health Evaluation (APACHE) IV-score on
admission [24], daily Sequential Organ Failure Assessment
(SOFA) scores [25], reason for admission, and length of ICU
stay. Routine daily collected measurements of sNa, serum
creatinine concentration, and serum urea concentration were
used. sNa was measured with point-of-care-testing (POCT,
ABL800 AutoCheck, Radiometer Pacific Pty. Ltd., Aus-
tralia and New Zealand). In addition, registration of total
sodium intake (including enteral and parenteral feeding,
administered fluids, and sodium content of administered
drugs and their solvents), fluid balance (derived from PDMS
minus 500mL anticipated insensible loss/day), diuresis, and
administration of diuretics were part of daily routine. Urine
cation excretion was calculated as the sum of urine sodium
and potassium concentrations derived from a spot urine
sample. A local ethics board (Regionale Toetsingscom-
missie Patie¨ntgebonden Onderzoek, Leeuwarden, Nether-
lands) waived the need for informed consent, according to
applicable laws.
2.3. Statistical Analysis. Data were collected in and analysed
with SPSS 20 (IBM,NewYork,USA). Distribution of datawas
evaluated by histograms and Shapiro-Wilk testing. Data are
expressed as median with interquartile range (IQR) or as a
number with the corresponding percentage.
In the balance study, sNa was used as a dichotomous
variable to determine the difference in total sodium intake
and fluid balance between groups after 24 and 48 hours.
Applicable tests for independent variables were conducted
to compare groups. Outcomes were considered significant at
𝑝 ≤ 0.05. Backwards multivariate logistic regression analysis
was performed, including all variables with a 𝑝 value ≤ 0.25
in the univariate analysis. In case of categorical variables,
the first category served as reference. Probability for stepwise
entry and removal were set at 0.05. Outcomes are expressed
as odds ratio (OR) with a confidence interval (CI) of 95%.
3. Results
3.1. Balance Study. During the study period, 97 patients were
eligible for inclusion. 47 patients were included in the IAH
group (sNa ≥ 143mmol/L) and 50 patients in the non-IAH
group (sNa < 143mmol/L).
Baseline characteristics are presented in Table 1. Apart
from severity of illness scores, which were higher in patients
developing IAH, there was no significant difference between
groups at baseline.
Median number of days until fulfilment of the IAH-
criterion was 3 [2–4]; median duration of sNa ≥ 143mmol/L
was 3 days [1–9]. Total sodium intake after 48 hours was
12.5 [9.3–17.5] grams in the non-IAH group versus 15.8 [9–
21.9] grams in the IAH group, 𝑝 = 0.13. Fluid balances were
positive in both groups and did not differ between groups at
24 and 48 hours after admission. Central venous pressure, as
an indirect parameter of volume status, did not differ between
groups (Tables 2 and 3 and Figure 1). Spot urine samples
were available from 22 patients with IAH. Median amount of
sodium in these samples was 45mmol/L [10–94].
Length of stay of patients with IAH was significantly
longer in comparison to the control group (4 [3–5] versus 6
[4–12], 𝑝 < 0.001, Table 2). In a multivariate logistic regres-
sion analysis, severity of illness, defined by APACHE IV-
scores, remained as the only significant factor in the develop-
ment of IAH (OR 1.020 (CI 1.004–1.035),𝑝 = 0.01). Analysing
data with sNa ≥ 145mmol/L as an alternative cutoff value
for IAH did not significantly change outcomes. These data
are provided in the electronic supplemental material (ESM)
available online at http://dx.doi.org/10.1155/2016/9571583.
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Table 1: Baseline characteristics balance study. sNa: serum sodium concentration.
s[Na] < 143mmol/L s[Na] ≥ 143mmol/L 𝑝 value
Number of patients, 𝑛 (%) 50 (51) 47 (49)
Male gender, 𝑛 (%) 34 (68) 29 (62) 0.53
Age, years 66 [61–73] 67 [57–77] 0.57
APACHE IV-score 58 [44–77] 68 [56–101] 0.01
SOFA score on admission 6 [4–8] 7 [4–10] 0.16
Reason for admission, 𝑛 (%)
Cardiovascular surgery 25 (50) 14 (30)
0.07
Sepsis 4 (8) 7 (15)
Elective surgery 3 (6) 2 (4)
Emergency surgery 10 (20) 5 (11)
Cardiopulmonary 4 (8) 8 (17)
resuscitation
Miscellaneous 4 (8) 11 (23)
Serum sodium on admission, mmol/L 138 [136–140] 138 [136–140] 0.25
Serum creatinine on admission, 𝜇mol/L 93 [71–117] 85 [69–113] 0.55
Serum urea on admission, mmol/L 7 [5–7] 6 [5–8] 0.44
APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment. Data are presented as median [IQR] or as absolute
numbers (%).
Table 2: Main results balance study.
s[Na] < 143mmol/L s[Na] ≥ 143mmol/L 𝑝 value
Length of stay, days 4 [3–5] 7 [4–15] <0.001
SOFA score after 24 hours 6 [4–7] 8 [5–10] 0.02
SOFA score after 48 hours 5 [3–6] 7 [4–10] <0.001
Fluid intake after 24 hours, L 4.4 [3.7–5.6] 3.8 [2.9–6.3] 0.54
Fluid intake after 48 hours, L 7.5 [6–9.2] 6.9 [5.3–9.2] 0.59
Fluid balance after 24 hours, L1 2 [1–2.8] 1.6 [0.6–3.7] 0.78
Fluid balance after 48 hours, L1 2.3 [1–3.7] 2.5 [0.8–4.2] 0.77
Sodium intake after 24 hours, grams 9.6 [6.9–11.8] 9.7 [5.9–15.8] 0.70
Sodium intake after 48 hours, grams 12.5 [9.3–17.5] 15.8 [9–21.9] 0.13
Serum creatinine after 24 hours, 𝜇mol/L 87 [66–130] 81 [65–110] 0.40
Serum creatinine after 48 hours, 𝜇mol/L 79 [60–116] 77 [61–121] 0.91
Serum urea after 24 hours, mmol/L 8 [6–10] 7 [5–11] 0.47
Serum urea after 48 hours, mmol/L 8 [6–12] 9 [5–13] 0.71
Number of patients on furosemide after 24 h 5 4 1
Total dose furosemide after 24 h, mg 20 [20–60] 60 [25–400] 0.29
Number of patients on furosemide after 48 h 18 15 0.83
Total dose furosemide after 48 h, mg 30 [20–60] 40 [20–60] 0.19
sNa: serum sodium concentration; SOFA: Sequential Organ Failure Assessment. 1Fluid balances are as extracted from the patient data management system,
minus 500mL of expected insensible loss per day of admission. Data are presented as median [IQR] or as absolute numbers (%).
Table 3: Central venous pressure.
s[Na] < 143mmol/L s[Na] ≥ 143mmol/L 𝑝 value
CVP admission, mmHg MV (𝑛 = 70) 10 [8–11] 11 [9–12] 0.05
No MV (𝑛 = 7) 𝑛 = 2 𝑛 = 5 NA
CVP 24 hours, mmHg MV (𝑛 = 45) 8 [5–11] 9 [5–12] 0.78
No MV (𝑛 = 32) 6 [4–9] 5 [2–8] 0.20
CVP 48 hours, mmHg MV (𝑛 = 30) 7 [3–11] 9 [6–12] 0.40
No MV (𝑛 = 47) 5 [2–8] 6 [2–9] 0.58
CVP: central venous pressure; MV: mechanical ventilation; NA: not applicable.
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Table 4: Baseline characteristics renal cation excretion study.
Group 1 (uNa + uK < sNa) Group 2 (uNa + uK ≥ sNa) 𝑝 value
Number of patients, 𝑛 (%) 99 (86) 16 (14)
Male gender, 𝑛 (%) 74 (75) 9 (56) 0.14
Age, years 67 [57–74] 63 [42–70] 0.44
APACHE IV-score 88 [68–116] 62 [51–80] 0.02
SOFA score on admission 8 [7–11] 7 [5–9] 0.26
Reason for admission, 𝑛 (%)
Cardiovascular surgery 18 (18) 2 (12)
0.74
Sepsis 33 (34) 6 (38)
Elective surgery 6 (6) 3 (19)
Emergency surgery 5 (5) 0 (0)
Cardiopulmonary 12 (12) 0 (0)
resuscitation
Miscellaneous 25 (25) 5 (31)
Serum sodium on admission, mmol/L 137 [135–139] 139 [136–141] 0.16
Serum creatinine on admission, 𝜇mol/L 94 [79–129] 78 [72–105] 0.22
Serum urea on admission, mmol/L 8 [6–12] 7 [5–8] 0.05
uNa: urine sodium concentration; uK: urine potassium concentration; sNa: serum sodium concentration; APACHE: Acute Physiology and Chronic Health
Evaluation; SOFA: Sequential Organ Failure Assessment. Data are presented as median [IQR] or as absolute numbers (%).





























Figure 1: Total sodium intake and fluid balance 48 hours after
admission in patients with and without developing IAH. sNa: serum
sodium concentration.
3.2. Renal Cation Excretion Study. Renal cation excretion
was measured in 115 patients with IAH. 99 patients were
included in the group with low cation excretion (uNa + uK <
sNa) and 16 patients in the group with high cation excretion
(uNa + uK ≥ sNa). Baseline characteristics are provided in
Table 4. At the time of urine analysis, median sNa in group
1 was 144 [143–147]mmol/L versus 145 [143–146]mmol/L in
group 2 (𝑝 = 0.85). Median sodium excretion was 38 [15–
67]mmol/L in group 1 and 133 [104–152]mmol/L in group
2 (𝑝 < 0.001). Potassium excretion was also significantly
lower in group 1 (36mmol/L versus 45mmol/L, 𝑝 < 0.001).
In a multivariate logistic regression model, APACHE IV
remained the only significant independent predictive variable
for low urine cation excretion.
4. Discussion
The balance study showed that development of IAH is not
fully explained by differences in sodium intake or fluid
balance. Our data do not seem to be completely in line with
previous literature and with the equation as described by
Edelman. Over the last decades, the common opinion has
been that IAH is a primary iatrogenic problem caused by
either sodium overload, lack of adequate water intake, or a
combination [1, 12, 14, 16, 18–20, 26–28]. However original
data on the differences in sodium intake and fluid balance
between ICU patients with and without IAH seem to be
scarce. In addition, some authors have focused on specific
sources of sodium intake, such as resuscitation fluids or
line flushing [18]. Our PDMS provided us the opportunity
to incorporate all sources of sodium intake, including tube
feeding andmedication. In addition, populations investigated
in previous publications were considerably smaller than in
our study [20, 26]. Lastly, an important difference between
this study and previous publications is the cutoff value for
IAH. We deliberately chose 143mmol/L as cutoff value since
Darmon et al. demonstrated the potential detrimental effects
of even mildly elevated sNa in critically ill patients [7].
In previous studies, a cutoff value of 145mmol/L or even
150mmol/L was not uncommon [1, 12, 14, 18–20, 26–28].
This reflects not only the change in mindset with respect
to the relevance of IAH, but also the focus on the reduction of
excessive sodium intake due to fluid overload and fluid com-
position in comparison to previous literature. It is conceivable
that in previous publications the widespread use of “isotonic”
saline in combination with more liberal infusion triggers has
been a contributing factor in the development of IAH [12].
However, even in our setting, with tight infusion triggers and
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lower sodium content of resuscitation fluids, median sodium
intake is far beyond the recommended daily amount of 2.6 g
sodium and a specific group of ICU patients still develops
IAH [6]. This suggests both differences in sodium handling
between patients that do and do not develop hypernatremia
and the potential for other contributing factors in the devel-
opment of IAH not yet identified.
The study on renal cation excretion revealed that most
patients with IAH seem to have an impairment in renal cation
excretion. Such inability to excrete cations was previously
suggested by others as a contributing factor in the aetiology
of IAH [14–16, 26, 27]. Indeed, in our study on renal
cation excretion, the vast majority of patients with IAH
displayed a total renal cation excretion below serum sodium
concentration. This is unlikely due to a water deficit, since
fluid balances were clearly positive. Strictly, this does not rule
out an absolute water deficit but makes it unlikely to be the
only contributing factor. Suggested mechanisms are tubular
dysfunction in the cause of acute renal failure or osmotic
diuresis as a result of enhanced urea excretion [16, 26, 29].
Although we did not measure urea excretion, the positive
fluid balances in our patients make excessive renal water loss
by osmotic diuresis as a cause of IAH unlikely.
If IAH cannot be explained by sodium intake or fluid
balance, the issue of an alternative explanation arises. The
fact that the APACHE IV-score, as markers of severity of
illness, was independently associated as risk factor for IAH
in the balance study and for low renal cation excretion,
respectively, fuels the idea of a more complex aetiology of
IAH. Such alternative explanation could be found in a third
compartment for storage of sodium. Already in 1910 Padtberg
mentioned this compartment [30]. Storage of osmotically
inactive sodium in (extremely) high concentrations has
been reported in cartilage, muscle, bone, and skin [31–33].
In healthy volunteers, water-free sodium storage has been
described [32]. In recent papers, attention to this com-
partment was renewed with focus on hypertension and its
treatment [34–36]. In animal and in vitro models, differences
in sodium storage capacity were found and appeared to
be related to the development of hypertension [34, 36].
Binding of sodium to proteoglycans seems to be the major
mechanism for intracutaneous nonosmotic sodium storage
and thereby serve as a conceivable third compartment.
Altered configuration with consequent changes in electrical
binding capacity has been suggested during inflammation
[37]. Our observation that IAH was related to severity of
illness, independent of sodium intake and fluid balance, may
be in line with an inflammation mediated pathway. Further
investigations on thesemechanisms in relation to IAH should
be initiated.
5. Limitations of the Study
Due to the retrospective single-centre design, this study
has its limitations. Full fluid and sodium balances were not
performed; sodium andwater content in sweat and stool were
left out of the equation. In this study, insensible loss of 500mL
per day was estimated [38, 39]. Urine analysis was limited to
spot urine samples and was restricted to patients with IAH.
ADH-concentrations, urine urea concentrations, and urine
osmolality were not measured. Mentioned fluid balances did
not include fluid administration prior to ICU admission. Due
to diurnal variation in renal sodium excretion spot urine
samples are not optimal in evaluating urine sodiumexcretion.
6. Conclusion
In spite of the current opinion, development of IAH is not
(fully) explained by sodium intake or fluid balance. This lack
of association between IAH and sodium intake and/or fluid
balance suggests other factors unaccounted for in the current
paradigm. Thereby, IAH does not seem to be a primary
iatrogenic complication. Severity of illness as an independent
risk factor for both IAH and low renal sodium excretion may
reflect other contributing factors, including sodium handling
in the third compartment, not yet identified. Therefore,
prospective studies concerning handling and distribution of
sodium and sodium balance, including hormone activity, to
unravel the complex aetiology of IAH are needed.
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